Impact of gastrointestinal disease states on oral drug absorption - implications for formulation design - a PEARRL review.

Development of suitable in vitro dissolution and in silico models for patients with GI diseases can improve their drug therapy. The likeliness of the models to provide accurate predictions depends on the knowledge of pathophysiological alterations, and thus, further assessment of physiological differences is essential.